Renalytix
Entity

  • Renalytix

  • BETA

    Up & running (A)
    Existing signals show a regular activity

  • Social networks

    3,369

  • Activities

    healthtech deeptech

  • Entity types

    Startup

  • Location

    1460 Broadway, New York, NY 10036, USA

    New York

    United States of America

  • Employees

    Scale: 51-200

    Estimated: 57

  • Engaged corporates

    0
    0 0

  • Added in Motherbase

    1 year, 3 months ago
Description
  • Value proposition

    Our singular goal is to eradicate kidney disease.

    Renalytix (LSE: RENX) (NASDAQ: RNLX) is the founder and global leader in the new field of bioprognosisTM for kidney health. We’ve engineered a proprietary solution that successfully enables early-stage, progression risk assessment when it counts the most.

    Renalytix. Right here, until kidney disease isn’t.TM

Corporate interactions BETA
Corporate TypeTweets Articles
No interactions
Similar entities
Last news
Show all articles
Social network dynamics